Tickwind
TodayOpportunitiesMarketsAI Chat
EN
Log inSign up
Tickwind

Read every tick. See where the market's blowing.

  • X
  • TelegramChinese
  • Newsletter

Product

  • Markets
  • Theme Zones
  • All stocks
  • Compare
  • Hot stocks
  • Opportunities
  • News
  • Discussion
  • Watchlist
  • What's new

Account

  • Settings
  • Newsletter
  • For writers
  • MCP server
  • Contact
  • Log in
  • Sign up
MarketsTheme ZonesAll stocksCompareHot stocksOpportunitiesNewsDiscussionWatchlistWhat's newSettingsNewsletterFor writersMCP serverContactLog inSign up

© 2026 Tickwind. Not investment advice.

Made for the curious investor.

Home/IPHA/Shareholders’ equity

Innate Pharma SA (IPHA) Shareholders’ equity

Innate Pharma SA (IPHA) shareholders’ equity at each fiscal year-end, per SEC filings.

No annual history for this metric yet

The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.

← Back to IPHA

Source: SEC XBRL filings · For reference only · Not investment advice

More IPHA financial trends

IPHA RevenueIPHA Net incomeIPHA Net marginIPHA Gross profitIPHA Gross marginIPHA Operating incomeIPHA Operating marginIPHA Operating cash flowIPHA Free cash flowIPHA Capital expendituresIPHA Return on equityIPHA Stock buybacksIPHA Dividends paidIPHA Total assetsIPHA Total liabilitiesIPHA overview →